References
- Health Insurance Institute of Slovenia. Rules of the Commission on enlisting drugs for public financing [Slovenian]. Ljubljana: Health Insurance Institute of Slovenia, 2014. Accessed March 26th, 2019 at:
http://www.pisrs.si/Pis.web/pregledPredpisa?id=PRAV11493 . - Ministry of Health of Republic of Slovenia. Procedures on handling the applications for new health care programmes [Slovenian]. Ljubljana: Ministry of Health, 2015. Accessed April 20th, 2019 at:
http://www.mz.gov.si/si/o_ministrstvu/zdravstveni_svet_in_ostala_posvetovalna_telesa/zdravstveni_svet/postopek_za_vloge/ . - Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96:5–21. doi: 10.1093/bmb/ldq033.
- Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5:1–30.
- Parkin D, Devlin N. Is there a case for using Visual Analogue Scale valuations in Cost-Utility Analysis? Report No. 04/03. London: Department of Economics, City University London, 2004. Accessed March 20th, 2019 at:
http://openaccess.city.ac.uk/1428/1/0403_parkin-devlin.pdf . - Tolley K. What are health utilities? NPR09/1103. Accessed February 17th, 2019 at:
http://www.bandolier.org.uk/painres/download/What%20is%202009/What_are_health_util.pdf . - von Neumann J, Morgenstern O. Theory of games and economic behavior. Princeton: University Press, 1944.
- Buckingham K, Devlin N, Tabberer M. A theoretical framework for TTO valuations and a taxonomy of TTO approaches: results from a pilot study. Department of Economics Discussion Paper Series 04/07. London: City University London, Department of Economics, 2007.
- EQ-5D, an instrument to describe and value health. Accessed April 29th, 2019 at:
https://euroqol.org/euroqol/ - Brauer CA, Rosen AB, Greenberg D, Neumann PJ. Trends in the measurement of health utilities in published cost-utility analyses. Value Health. 2006;9:213–8. doi: 10.1111/j.1524-4733.2006.00116.x.
- van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15:708–15. doi: 10.1016/j.jval.2012.02.008.
- Prevolnik Rupel V, Rebolj M. The Slovenian VAS tariff based on valuations of EQ-5D health states from the general population. In: Cabases JM, Gaminde I. 17th Plenary Meeting of the EuroQol Group, Discussion Papers. Pamplona: EuroQol Group, 2000.
- Prevolnik Rupel V, Ogorevc M. The EQ-5D health states value set for Slovenia. Zdr Varst 2012;51:128–40. doi: 10.2478/v10152-012-0015-y.
- Gudex C. Time trade-off user manual: props and self-completion methods. York: The University of York, Centre for Health Economics, 1994.
- Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goñi JM, Luo N. EuroQol protocols for time trade-off valuation of health outcomes. Pharmacoeconomics. 2016;34:993–1004. doi: 10.1007/s40273-016-0404-1.
- Devlin NJ, Hansen P, Kind P, William AH. The health states preferences and logical inconsistencies of New Zealanders: a tale of two tariffs. In: Cabases JM, Gaminde I. Pamplona: 17th Plenary Meeting of the EuroQol Group, Discussion Papers, 2000.
- Kind P. Improving the MVH protocol: learning from the past. Work in progress.
- Rand-Hendriksen K., Ramos-Goñi JM, Augestad LA, Luo N. Less is more: cross-validation testing of simplified nonlinear regression model specifications for EQ-5D-5L health state values. Value Health. 2017;20:945–52. doi: 10.1016/j.jval.2017.03.013.
- Hoerl AE, Kennard RW. Ridge regression: biased estimation for nonorthogonal problems. Technometrics. 1970;12:55–67. doi: 10.2307/1271436.
- Tibshirani R. Regression shrinkage and selection via the lasso. J. R. Statist. Soc. B. 1996;58:267–88.
- Zou H, Hastie T. Regularization and variable selection via the elastic net. J. R. Statist. Soc. B. 2005;67:301–20.
- Nan L, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L value set for China. Value Health. 2017;20:662–9. doi: 10.1016/j.jval.2016.11.016.
- Shafie AA, Vasan Thakumar A, Lim CJ, Luo N, Rand-Hendriksen K, Md Yusof FA. EQ-5D-5L valuation for the Malaysian population. Pharmacoeconomics. 2019;37:715–25. doi: 10.1007/s40273-018-0758-7.
- Ramos-Goñi JM, Pinto-Prades JL, Oppe M, Cabasés JM, Serrano-Aguilar P, Rivero-Arias O. Valuation and modeling of EQ-5D-5L health states using a hybrid approach. Med Care. 2017;55:e51–8. doi: 10.1097/MLR.0000000000000283.
- Golicki D, Jakubczyk M, Niewada M, Wrona W, van Busschback JJ. Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe. Value Health. 2010;13:289–97. doi: 10.1111/j.1524-4733.2009.00596.x.
- Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095–108.
- Greiner W, Weijnen T, Nieuwenhuizen M, et al. A single European currency for EQ-5D health states. Eur J Health Econ. 2003;4:222–31. doi: 10.1007/s10198-003-0182-5.
- R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2016. Accessed February 17th, 2019 at:
https://www.R-project.org/ . - RStudio Team. RStudio: integrated development for R. Accessed May 20th, 2019 at:
www.rstudio.com . - Wickham H. Ggplot2 – Elegant Graphics for Data Analysis. 2nd ed. New York: Springer-Verlag, 2016.
- Rand K. xreg: flexible multi-frame non-linear regression model. Accessed May 17th, 2019 at:
https://www.github.com/intelligentaccident/xreg . - Zrubka Z, Beretzky Z, Hermann Z, Brodszky V, Gulácsi L, Rencz F, et al. A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases. Eur J Health Econ. 2019;20(Suppl 1):119–32. doi: 10.1007/s10198-019-01069-8.
- Rencz F, Gulácsi L, Drummond M, Golicki D, Prevolnik Rupel V, Simon J, et al. EQ-5D in Central and Eastern Europe: 2000–2015. Qual Life Res. 2016;25:2693–710. doi: 10.1007/s10198-019-01069-8.